Jason Hart

1.0k total citations
18 papers, 703 citations indexed

About

Jason Hart is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jason Hart has authored 18 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Jason Hart's work include Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). Jason Hart is often cited by papers focused on Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). Jason Hart collaborates with scholars based in Canada, United States and India. Jason Hart's co-authors include Emmanuelle Waubant, Jennifer Graves, Douglas Fadrosh, Feng Zhu, Shalini Lynch, Shelly Roalstad, Helen Tremlett, Ali A. Faruqi, Pauline T. Truong and Cheryl Alexander and has published in prestigious journals such as Blood, Psychosomatic Medicine and Annals of Surgical Oncology.

In The Last Decade

Jason Hart

18 papers receiving 689 citations

Peers

Countries citing papers authored by Jason Hart

Since Specialization

Citations

This map shows the geographic impact of Jason Hart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Hart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Hart more than expected).

Fields of papers citing papers by Jason Hart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Hart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Hart. The network helps show where Jason Hart may publish in the future.

Co-authorship network of co-authors of Jason Hart

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Hart. A scholar is included among the top collaborators of Jason Hart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Hart. Jason Hart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	First-line osimertinib for patients with EGFR-mutated advanced non-small cell lung cancer: efficacy and safety during the COVID-19 pandemic 2023 ·Translational Lung Cancer Research ·(unknown), Pauline T. Truong, Jeffrey N. Bone, Curtis Hughesman, Stephen Yip, Deepu Alex, Jason Hart, Philip H. Pollock, (unknown), (unknown), Mary Lesperance, Doran Ksienski	5
2	Safety and efficacy of pembrolizumab for advanced nonsmall cell lung cancer: before and during the COVID-19 pandemic 2022 ·Journal of Cancer Research and Clinical Oncology ·Doran Ksienski, Sapna Gupta, Pauline T. Truong, Jeffrey N. Bone, Angela Chan, Deepu Alex, Jason Hart, Philip H. Pollock, (unknown), (unknown), (unknown), (unknown), Mary Lesperance	2
3	Locoregional Treatments for Metastatic Gastrointestinal Stromal Tumor in British Columbia: A Retrospective Cohort Study from January 2008 to December 2017 2022 ·Cancers ·(unknown), Haocheng Li, (unknown), (unknown), Christine Simmons, Jason Hart, (unknown), Caroline L. Holloway, Pauline T. Truong, Xiaolan Feng	9
4	Utilization of Mutational Analysis (MA) in Gastrointestinal Stromal Tumor (GIST) Management in British Columbia (BC) Between January 2008 to December 2017: a Retrospective Population-Based Study 2021 ·Journal of Gastrointestinal Cancer ·(unknown), (unknown), Haocheng Li, (unknown), (unknown), Cheng‐Han Lee, Steven Yip, Christine Simmons, Jason Hart, (unknown), Caroline L. Holloway, Pauline T. Truong, Xiaolan Feng	2
5	Evolving Practice Patterns Over Two Decades (1993–2013) in the Management of Desmoid-type Fibromatosis in British Columbia 2019 ·Clinical Oncology ·(unknown), (unknown), (unknown), Christine Simmons, Paul W. Clarkson, Kate Goddard, Peter L. Munk, Jason Hart, Caroline L. Holloway, (unknown), Xiaolan Feng	8
6	Gut microbiota in early pediatric multiple sclerosis: a case−control study 2016 ·European Journal of Neurology ·Helen Tremlett, Douglas Fadrosh, Ali A. Faruqi, Feng Zhu, Jason Hart, Shelly Roalstad, Jennifer Graves, Shalini Lynch, Emmanuelle Waubant	276
7	Successful treatment of non‐Hodgkin lymphoma associated immune thrombocytopenia with involved field radiotherapy 2013 ·Hematological Oncology ·Tanya Berrang, Caroline Holloway, Jason Hart, (unknown), Brian Berry, Rami Kotb	5
8	Treatment and Outcomes of Primary Breast Lymphoma 2012 ·Clinical Breast Cancer ·Julianna Caon, Elaine S. Wai, Jason Hart, Cheryl Alexander, Pauline T. Truong, Laurie H. Sehn, Joseph M. Connors	35
9	Rituximab for Management of Refractory Pregnancy-Associated Immune Thrombocytopenic Purpura 2010 ·Journal of Obstetrics and Gynaecology Canada ·(unknown), (unknown), Brian Berry, (unknown), Allen Hayashi, Jerome Dansereau, Jason Hart	29
10	Primary Sarcoma of the Mediastinum: A Report of 16 Cases Referred to the British Columbia Cancer Agency 2010 ·Journal of Thoracic Oncology ·(unknown), Pauline T. Truong, Jason Hart, Stuart Jones, (unknown), (unknown), Cheryl Alexander, Howard Joe	20
11	Population-Based Analysis of the Frequency of Anemia and its Management Before and During Chemotherapy in Patients With Malignant Lymphoma 2010 ·American Journal of Clinical Oncology ·Pauline T. Truong, (unknown), Jason Hart, Cheryl Alexander, Elaine S. Wai	10
12	Treatment and Outcomes in Adult Patients with Primary Cardiac Sarcoma: The British Columbia Cancer Agency Experience 2009 ·Annals of Surgical Oncology ·Pauline T. Truong, Stuart Jones, (unknown), Cheryl Alexander, (unknown), Howard Joe, Jason Hart, Sharon J. Allan	66
13	Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone 2009 ·Blood ·Emanuela Carlotti, David Wrench, Janet Matthews, Sameena Iqbal, Andrew Davies, A. J. Norton, Jason Hart, Raymond Lai, Silvia Montoto, John G. Gribben, T. Andrew Lister, Jude Fitzgibbon	95
14	Determining the Mechanism of Transformation of Follicular Lymphoma into Diffuse Large B Cell Lymphoma. 2007 ·Blood ·Emanuela Carlotti, David Wrench, Sameena Iqbal, Derville O’Shea, Andrew Davies, (unknown), Jason Hart, Raymond Lai, John G. Gribben, Andrew Lister, Jude Fitzgibbon	1
15	An investigation of myocardial aerobic capacity as a measure of both physical and cognitive workloads 2005 ·International Journal of Industrial Ergonomics ·Tycho K. Fredericks, Sang D. Choi, Jason Hart, Steven E. Butt, Anil Mital	61
16	RESOLUTION OF HELICOBACTER PYLORI‐ASSOCIATED GASTRIC LYMPHOPROLIFERATIVE DISEASE IN A CHILD 1995 ·Journal of Pediatric Gastroenterology and Nutrition ·Uwe Blecker, (unknown), Jason Hart, Barbara S. Kirschner	7
17	Analysis of clinicopathologic prognostic features in patients with gastric adenocarcinoma. 1994 ·PubMed ·Fabrizio Michelassi, (unknown), (unknown), Jason Hart, (unknown), (unknown)	33
18	Behavioral treatment of essential hypertension: a comparison between cognitive therapy and biofeedback of heart rate. 1989 ·Psychosomatic Medicine ·(unknown), (unknown), Meredith R. Golomb, Jason Hart	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact